The FDA picked the LP.8.1 Covid strain for the fall vaccines, fueling concerns that the shots may be limited to only the most ...

A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make ...

Government vaccine advisers are meeting to decide if the recipe for COVID-19 vaccines needs updating for this fall and winter ...

The vaccine eligibility change is a threat to the health of Americans, some experts say, adding that the FDA is not being ...

Low uptake may reflect barriers—misinformation, access or shifting insurance coverage—not simply waning need.

The advisory committee meeting comes days after the FDA unveiled a new risk-based approval framework for COVID-19 vaccines.

Despite the fact that vaccines against COVID have already undergone strict safety reviews and that people continue to die ...

The FDA will limit the vaccine’s availability later this year to older adults and those who may be at risk of severe illness.

Despite an explanation of the new strategy published Tuesday from FDA Commissioner Marty Makary and Vinay Prasad, who ...

The advisory committee, which met after the agency rolled out new vaccine guidelines, said companies should tailor their ...

The US FDA may limit Covid-19 boosters to high-risk groups only, citing lack of efficacy in healthy individuals. Meanwhile, ...

At the outset of the meeting, the FDA's new top vaccine regulator, Vinay Prasad, said he and FDA leaders wanted to "give people a little more time to digest the policy." He said that the FDA is still ...